Fibrinolysis

Trauma Induced Coagulopathy

Volumn , Issue , 2016, Pages 135-147

  Moore, Hunter B ^a   Moore, Ernest E ^a   Gonzalez, Eduardo ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrinolysis; Fibrinolysis shutdown; Hyperfibrinolysis; Physiologic fibrinolysis; Trauma

Indexed keywords

EID: 84978209229     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-28308-1_9     Document Type: Chapter

References (61)

1. Macfarlane RG, Biggs R. Fibrinolysis; its mechanism and significance. Blood. 1948;3:1167-87.
2. Stafford JL. The fibrinolytic mechanism in haemostasis: a review. J Clin Pathol. 1964;17:520-30.
3. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659-76.
4. Hardaway RM. Microcoagulation in shock. Am J Surg. 1965;110:298-301.
5. Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014;77:811-7. discussion 817.
6. Levin EG, del Zoppo GJ. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol. 1994;144:855-61.
7. Chakrabarti R, Fearnley GR. The ‘fibrinolytic potential’ as a simple measure of spontaneous fibrinolysis. J Clin Pathol. 1962;15:228-30.
8. Katz J, Lurie A, Becker D, Metz J. The euglobulin lysis time test: an ineffectual monitor of the therapeutic inhibition of fibrinolysis. J Clin Pathol. 1970;23:529-32.
9. Brass LF, Zhu L, Stalker TJ. Minding the gaps to promote thrombus growth and stability. J Clin Invest. 2005;115:3385-92.
10. Brass LF, Stalker TJ. Minding the gaps--and the junctions, too. Circulation. 2012;125:2414-6.
11. Moore HB, Moore EE, Gonzalez E, Hansen KC, Dzieciatkowska M, et al. Hemolysis exacerbates hyperfibrinolysis while platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury. Shock. 2015;43:39.
12. Chapman MP, Moore EE, Ramos CR, Ghasabyan A, Harr JN, et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg. 2013;75:961-7.
13. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg. 2012;73:365-70. discussion 370.
14. Schochl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67:125-31.
15. Chakrabarti R, Hocking ED, Fearnley GR. Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen. J Clin Pathol. 1969;22:659-62.
16. Raza I, Davenport R, Rourke C, Platton S, Manson J, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11:307-14.
17. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64:1211-7. discussion 1217.
18. Kutcher ME, Ferguson AR, Cohen MJ. A principal component analysis of coagulation after trauma. J Trauma Acute Care Surg. 2013;74:1223-9. discussion 1229-1230.
19. Chin TL, Moore EE, Moore HB, Gonzalez E, Chapman MP, et al. A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis. Surgery. 2014; 156:570.
20. Schochl H, Cadamuro J, Seidl S, Franz A, Solomon C, et al. Hyperfibrinolysis is common in out-ofhospital cardiac arrest: results from a prospective observational thromboelastometry study. Resuscitation. 2013;84:454-9.
21. Hayakawa M, Gando S, Ieko M, Honma Y, Homma T, et al. Massive amounts of tissue factor induce fibrinogenolysis without tissue hypoperfusion in rats. Shock. 2013;39:514-9.
22. Stein SC, Chen XH, Sinson GP, Smith DH. Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury. J Neurosurg. 2002;97:1373-7.
23. Maeda T, Katayama Y, Kawamata T, Aoyama N, Mori T. Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. Acta Neurochir Suppl. 1997;70:102-5.
24. Kashuk JL, Moore EE, Sawyer M, Wohlauer M, Pezold M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252:434-42. discussion 443-444.
25. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007;245:812-8.
26. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebocontrolled trial. Lancet. 2010;376:23-32.
27. Sherry S, Fletcher AP, Alkjaersig N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev. 1959; 39:343-82.
28. Wiener G, Moore HB, Moore EE, Gonzalez E, Diamond S, et al. Shock releases bile acid inducing platelet inhibition and fibrinolysis. J Surg Res. 2015;195:390.
29. Groth CG, Pechet L, Starzl TE. Coagulation during and after orthotopic transplantation of the human liver. Arch Surg. 1969;98:31-4.
30. Otter M, Kuiper J, van Berkel TJ, Rijken DC. Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver. Ann N Y Acad Sci. 1992;667:431-42.
31. Einarsson M, Smedsrod B, Pertoft H. Uptake and degradation of tissue plasminogen activator in rat liver. Thromb Haemost. 1988;59:474-9.
32. Cardenas JC, Matijevic N, Baer LA, Holcomb JB, Cotton BA, et al. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock. 2014;41:514-21.
33. Garcia-Avello A, Lorente JA, Cesar-Perez J, Garcia- Frade LJ, Alvarado R, et al. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res. 1998;89:59-64.
34. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care. 2007;13:680-5.
35. Kuramoto M, Yamashita J, Ogawa M. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells. Cancer. 1995;75:1263-72.
36. Kostousov V, Wang YW, Cotton BA, Wade CE, Holcomb JB, et al. Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole- blood model. Blood Coagul Fibrinolysis. 2013;24:489-97.
37. Hardaway RM. The role of intravascular clotting in the etiology of shock. Ann Surg. 1962;155:325-38.
38. Robb HJ. The role of micro-embolism in the production of irreversible shock. Ann Surg. 1963; 158:685-97.
39. Hardaway RM, Burns JW. Mechanism of action of fibrinolysin in the prevention of irreversible hemorrhagic shock. Ann Surg. 1963;157:305-9.
40. Hardaway RM, James Jr PM, Anderson RW, Bredenberg CE, West RL. Intensive study and treatment of shock in man. JAMA. 1967;199:779-90.
41. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601-6.
42. Schultz DJ, Brasel KJ, Washington L, Goodman LR, Quickel RR, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma. 2004;56:727-31. discussion 731-733.
43. Kwaan HC. Microvascular thrombosis: a serious and deadly pathologic process in multiple diseases. Semin Thromb Hemost. 2011;37:961-78.
44. Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med. 2010; 38:S35-42.
45. Prakash S, Verghese S, Roxby D, Dixon D, Bihari S, et al. Changes in fibrinolysis and severity of organ failure in sepsis: a prospective observational study using point-of-care test-ROTEM. J Crit Care. 2015;30:264.
46. Schochl H, Solomon C, Schulz A, Voelckel W, Hanke A, et al. Thromboelastometry (TEM) findings in disseminated intravascular coagulation in a pig model of endotoxinemia. Mol Med. 2011;17:266-72.
47. Ostrowski SR, Berg RM, Windelov NA, Meyer MA, Plovsing RR, et al. Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers. PLoS One. 2013;8:e59368.
48. Rancourt RC, Ahmad A, Veress LA, Rioux JS, Garlick RB, et al. Antifibrinolytic mechanisms in acute airway injury after sulfur mustard analog inhalation. Am J Respir Cell Mol Biol. 2014;51:559-67.
49. Enderson BL, Chen JP, Robinson R, Maull KI. Fibrinolysis in multisystem trauma patients. J Trauma. 1991;31:1240-6.
50. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin- fibrinogen interactions. Acta Anaesthesiol Scand. 2005;49:1163-71.
51. Bickell WH, Wall Jr MJ, Pepe PE, Martin RR, Ginger VF, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331:1105-9.
52. Brown JB, Cohen MJ, Minei JP, Maier RV, West MA, et al. Goal-directed resuscitation in the prehospital setting: a propensity-adjusted analysis. J Trauma Acute Care Surg. 2013;74:1207-12. discussion 1212-1224.
53. Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013;74:1575-86.
54. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg. 2012;147:113-9.
55. Valle EJ, Allen CJ, Van Haren RM, Jouria JM, Li H, et al. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg. 2014;76:1373-8.
56. Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, et al. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma. 2011;71:S318-28.
57. Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, et al. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg. 2013;148:218-25.
58. He S, Johnsson H, Zabczyk M, Hultenby K, Wallen H, et al. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates. Thromb Haemost. 2014;111:417-28.
59. Hoppe B. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation. Thromb Haemost. 2014;112:649-58.
60. Ramanathan A, Karuri N. Fibronectin alters the rate of formation and structure of the fibrin matrix. Biochem Biophys Res Commun. 2014;443:395-9.
61. Hardaway RM, Harke H, Tyroch AH, Williams CH, Vazquez Y, et al. Treatment of severe acute respiratory distress syndrome: a final report on a phase I study. Am Surg. 2001;67:377-82.